Int J Pharm Pract 2001:9:225-234
Department of Pharmacy, King's College London, England
Marilyn A. Ewan, PhD, MRPharmS, postgraduate
research pharmacist
Russell Greene, PhD, MRPharmS, senior lecturer
in clinical pharmacy
Correspondence:
Dr Ewan, c/o Dr R. J. Greene, Department of Pharmacy,
King's College London, Franklin-Wilkins Building, 150 Stamford Street,
London, England SE1 8WA
malewan@hotmail.com
|
Original Papers
Evaluation of mental health care interventions made by three community
pharmacists - a pilot study
M. A. Ewan and R. J. Greene
Objective To assess the clinical significance of drug-related
interventions made by three community pharmacists (CPs) in the pharmaceutical
care of 30 long-term mentally ill patients in the UK.
Method Three CPs ("study pharmacists") participated
in a nine-month study in which they collaborated with the community mental
health team (CMHT) to provide pharmaceutical care for long-term mentally
ill patients in the community. In particular, they liaised with the patients'
keyworkers, accompanying them on home visits. The pharmacists had previously
attended a specially organised training course. Their primary tasks were
to assess patient need and identify medication-related problems, intervene
as appropriate and document patient outcome. An expert review panel (two
specialist hospital mental health pharmacists and a consultant psychiatrist)
evaluated the appropriateness of the interventions and the level of clinical
significance of the interventions (using a validated four-point rating scale).
Key findings Thirty-eight patients consented to participate
in the study and 35 were contactable. Ninety-four medication-related problems
were identified involving 30 patients (mean number of recorded problems
per patient=3), of which full data were available for 92. Eighty-four problems
(91 per cent; n=92) were said to have had appropriate interventions, and
eight (9 per cent) inappropriate interventions. In 35 per cent of problems
the three reviewers agreed that the interventions were clinically significant.
Inter-rater agreement for paired agreements (assessed by the kappa statistic)
was fair in all cases except one, where it was poor.
Conclusion The reviewers considered the study pharmacists
to have made a valuable pharmaceutical contribution to mental health care
through clinically significant interventions, although they identified cases
in which further clinically significant interventions could have been made.
The reviewers saw the work undertaken as providing a positive way forward
in primary mental health care. |